1. Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain 
Jeremy R. Johnson, MB ChB, Mary Burnell-Nugent, MB BChir, Dominique Lossignol, MB ChB, MRCG, DRCOG, Elena Doina Ganae- Motan, MD, Richard Potts, BSc (Hons), MICR, Marie T. Fallon, MB ChB, MD, FRCP (E), FRCP (Glasg) 
Journal of Pain and Symptom Management 
Volume 39, Issue 2, Pages (February 2010)
DOI: /j.jpainsymman
Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

2. Fig. 1
Study design (Consolidated Standards of Reporting Trials [CONSORT] diagram). ITT=intent to treat.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

3. Fig. 2
Exposure to study medication—mean number of sprays per day. SE=standard error.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

4. Fig. 3
Pain 0–10 Numerical Rating Scale scores: responder analysis (ITT analysis). aOdds ratio (95% CI) THC:CBD vs. placebo; bFisher’s exact test.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions